| Literature DB >> 23597362 |
Hilary L Surratt1, Steven P Kurtz, Theodore J Cicero, Catherine O'Grady, Maria A Levi-Minzi.
Abstract
The high cost of life-saving antiretroviral (ARV) therapy for HIV represents an expense that impedes accessibility and affordability by patients. This price structure also appears to motivate the diversion of ARVs and the targeting of HIV-positive patients by pill brokers in the illicit market. Our field research with indigent, HIV-positive substance abusers links ARV diversion to high levels of competing needs, including psychiatric disorders, HIV stigma, and homelessness. Interventions to reduce diversion must address the needs of highly vulnerable patients.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23597362 PMCID: PMC3670661 DOI: 10.2105/AJPH.2012.301092
Source DB: PubMed Journal: Am J Public Health ISSN: 0090-0036 Impact factor: 9.308